OnKure Therapeutics, Inc. OKUR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$59.52M-13.0% | -$52.67M— | —— | -$51.96M-30.6% | ||
| $447K-2.6% | $459K+10.1% | $417K+374% | $88K+76.0% | ||
| $11.63M+157% | $4.53M— | —— | $4.32M+11.0% | ||
| -$51.83M-1.4% | -$51.12M— | —— | -$47.36M-24.7% | ||
| $46K-11.5% | $52K-78.9% | $246K-28.9% | $346K+74.7% | ||
| -$46K-100% | $15.87M— | —— | -$57.84M— | ||
| —— | $6M— | —— | —— | ||
| —— | $116.13M— | —— | $471K-99.6% | ||
| -$51.71M-164% | $80.89M+341% | $18.33M+118% | -$104.73M— | ||
| -$51.87M-1.4% | -$51.17M— | —— | -$47.71M-25.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OnKure Therapeutics, Inc. generate?
- OnKure Therapeutics, Inc. (OKUR) generated -$50.8M in operating cash flow over the trailing twelve months.
- What is OnKure Therapeutics, Inc.'s free cash flow?
- After $33.0K of capital expenditures, OnKure Therapeutics, Inc.'s free cash flow was -$50.8M over the trailing twelve months, up 6.9% year over year.
- Where does OnKure Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.